Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis-Reference-Cited by-同舟云学术

Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis

Published:2017-05 Issue: Volume:130 Page:47-56
ISSN:1098-8823
Container-title:Prostaglandins & Other Lipid Mediators
language:en
Short-container-title:Prostaglandins & Other Lipid Mediators

Author:

Pulkoski-Gross Michael J.,Uys Joachim D.,Orr-Gandy K. Alexa,Coant Nicolas,Bialkowska Agnieszka B.,Szulc Zdzislaw M.,Bai Aiping,Bielawska Alicja,Townsend Danyelle M.,Hannun Yusuf A.,Obeid Lina M.,Snider Ashley J.

Publisher

Elsevier BV

Subject

Cell Biology,Pharmacology,Physiology,Biochemistry

Reference44 articles.

1. Principles of bioactive lipid signalling: lessons from sphingolipids;Hannun;Nature reviews. Molecular cell biology,2008

2. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate;Hait;Science,2009

3. Essential role for sphingosine kinases in neural and vascular development;Mizugishi;Mol. Cell. Biol,2005

4. Lymphocyte egress from thymus and peripheral lyphoid organs is deendent on S1P receptor 1;Matloubian;Nature,2004

5. Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages;Hammad;Prostaglandins & other lipid mediators,2008

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The diverse roles of sphingolipids in inflammatory bowel disease;The FASEB Journal;2024-06-27

2. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy;Cell Communication and Signaling;2024-05-02

3. GLP‐1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells;Immunology;2024-03-27

4. The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target;Cancer Cell International;2024-02-28

5. Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer;Cancers;2024-02-15